Skip to content
Disclosery

EXANE DERIVATIVES: JD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on JD, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 16,526 JD shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 16,526 shares
    Change vs previous 13F +9,749 shares

    0.61% of the 13F portfolio, value $1,061,104.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 6,777 shares
    Change vs previous 13F -446 shares

    0.11% of the 13F portfolio, value $392,154.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 7,223 shares
    Change vs previous 13F -3,113 shares

    0.12% of the 13F portfolio, value $506,094.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 10,336 shares
    Change vs previous 13F +2,815 shares

    0.19% of the 13F portfolio, value $746,608.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 7,521 shares
    Change vs previous 13F 0 shares

    0.13% of the 13F portfolio, value $575,494.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 7,521 shares
    Change vs previous 13F -4,126 shares

    0.19% of the 13F portfolio, value $634,218.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 11,647 shares
    Change vs previous 13F -4,398 shares

    0.31% of the 13F portfolio, value $1,023,724.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 16,045 shares
    Change vs previous 13F not available

    0.41% of the 13F portfolio, value $1,245,066.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).